DUNNING AND EVANS LTD
Company number 13557571 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
DUNNING AND EVANS LTD - Analysis Report
Company Number: 13557571
Analysis Date: 2025-07-29 20:17 UTC
Financial Health Assessment of DUNNING AND EVANS LTD
1. Financial Health Score: B-
Explanation:
DUNNING AND EVANS LTD demonstrates solid foundational financial health for a micro-entity in the construction sector with positive net assets and working capital. However, there are early signs of strain—particularly the increase in long-term liabilities and a reduction in net assets—that temper the overall score. The company remains solvent and operational but should address emerging financial stressors to sustain and improve health.
2. Key Vital Signs
| Metric | 2024 Value | Interpretation |
|---|---|---|
| Turnover (Latest Known) | £314,719 (2023) | Modest revenue growth indicating stable market activity for a micro business. |
| Fixed Assets | £57,945 | Significant increase from prior years, reflecting investment in long-term assets. |
| Current Assets | £76,157 | Healthy increase, suggesting stronger short-term liquidity. |
| Current Liabilities | £47,490 | Substantial rise compared to previous years, signaling increased short-term obligations. |
| Net Current Assets | £28,667 | Positive working capital but has decreased, indicating potential liquidity tightening. |
| Long-term Liabilities | £46,494 | New and sizeable debt appearing for the first time, raising concern about leverage. |
| Net Assets (Shareholders’ Funds) | £40,118 | Decline from £46,789 prior year, a symptom of emerging financial pressure. |
| Average Employees | 4 | Small workforce consistent with micro entity status. |
3. Diagnosis: What the Financial Data Reveals
Healthy Cash Flow Base: The company’s turnover grew from £160,619 in 2021 to £314,719 in 2023, showing successful market penetration and operational growth. This is akin to a patient gaining strength and resilience.
Asset Investment ("Capital Infusion"): Fixed assets increased sharply to nearly £58k in 2024 from £6.9k previously, indicating substantial investment in equipment or property. While this can fuel growth, it is crucial that such investments generate returns, or else they become a burden.
Liquidity Caution ("Short-Term Stress"): Current liabilities nearly tripled to £47,490, eroding net current assets from £39,889 to £28,667. This reduction in working capital signals that the company may face tighter cash flow conditions in the near term.
Leverage Warning ("Debt Burden"): The appearance of long-term liabilities at £46,494 introduces financial leverage not previously present. This increased debt load could strain the company if revenues or margins do not improve accordingly.
Equity Decline ("Net Worth Erosion"): Net assets decreased by over £6,600, a symptom that the company may be consuming capital or encountering losses, though exact profit/loss data is not provided.
Operational Scale: With only about four employees, the company remains a small, focused operation, which can be an advantage in flexibility but also limits scaling without additional resources.
4. Recommendations: Steps to Improve Financial Wellness
Monitor and Manage Debt Levels: The new long-term liabilities should be carefully managed. Explore refinancing options or negotiate terms to avoid cash flow strain. Consider whether the asset investments funded by this debt generate sufficient returns.
Strengthen Working Capital: Improve collection of receivables and manage payables to maintain or increase net current assets. Healthy working capital is like a strong pulse, essential for daily operations.
Enhance Profitability Tracking: Implement detailed profit and loss monitoring to diagnose whether net asset decline is due to operational losses or one-off costs. Early detection of negative trends allows timely intervention.
Cash Flow Forecasting: Conduct rolling cash flow forecasts to anticipate liquidity bottlenecks, ensuring the business can meet short-term obligations without distress.
Cost Control and Efficiency: Review operating expenses and project costs carefully to avoid margin erosion. Small companies often benefit from lean management practices.
Strategic Growth Planning: Align asset investments with strategic growth plans. Investments should be justified by projected cash inflows and market demand to avoid overextension.
Maintain Compliance and Reporting: Continue timely filing of accounts and confirmation statements to preserve corporate reputation and avoid penalties.
Medical Analogy Summary
DUNNING AND EVANS LTD currently exhibits a "stable but cautious" financial pulse. The business shows signs of healthy growth but reveals "symptoms of financial stress" through rising debt and shrinking net equity. Like a patient who has recently undergone a significant intervention (asset purchase funded by debt), the company needs close monitoring and supportive care (cash flow management and profitability focus) to ensure long-term wellness and avoid financial distress.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.